Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LOUISIANA PAIN CARE, LLC

NPI: 1659300739 · MONROE, LA 71201 · Interventional Pain Medicine Physician · NPI assigned 07/01/2006

$238K
Total Medicaid Paid
47,214
Total Claims
42,840
Beneficiaries
22
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialLEDBETTER, JOHN (PHYICIAN - OWNER)
NPI Enumeration Date07/01/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 7,748 $31K
2019 8,184 $32K
2020 7,355 $32K
2021 6,651 $30K
2022 5,544 $32K
2023 7,509 $37K
2024 4,223 $45K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 13,567 12,186 $110K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 14,760 13,500 $81K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 8,382 7,516 $24K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 3,839 3,683 $10K
62323 206 169 $3K
99152 1,477 1,141 $3K
99441 936 897 $2K
99454 290 282 $2K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 89 89 $823.13
99457 308 301 $703.64
64635 14 12 $577.33
99442 1,823 1,585 $428.50
64636 14 12 $313.69
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 43 40 $304.13
64493 14 12 $154.23
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,233 1,225 $146.41
64494 14 12 $52.30
20610 16 12 $37.06
J1030 Injection, methylprednisolone acetate, 40 mg 70 65 $6.43
99406 88 76 $0.00
99443 19 13 $0.00
96138 12 12 $0.00